Search

everythinglearnresearchcommunity

for

Search:↓

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Spironolactone helps regrow hair in women with hair loss.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

A model called PM-DBiGRU was developed for analyzing sentiments in drug reviews, and it performed better than other models, but struggled with complex sentences and situations requiring background knowledge.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

AR gene not major factor in female hair loss; different from male hair loss.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.